Thomas Lynch


Mr. Lynch has served as the Chairman of the board of directors of Evofem Biosciences since November 2015. Mr. Lynch also currently serves as Chairman of the Boards of Profectus Biosciences Inc, and Adherium Limited and as a nonexecutive director of GW Pharmaceuticals where he serves as Chairman of its compensation committee and as a member of its audit committee. Mr. Lynch is also the non-executive chairman of the Ireland East Hospital Group and the Mater Misericordiae University Hospital, a non-profit charitable foundation providing acute hospital services to both public and private patients.

Mr. Lynch serves on the board of a number of privately held biotechnology companies. Mr. Lynch previously served as Chairman of ICON PLC and was a member of its board for 21 years. Mr. Lynch was the Chairman and Chief Executive Officer of Amarin Corporation PLC from 2000 to 2010, Executive Vice President, Chief Financial Officer and director of Elan Corporation PLC from 1993 to 2004, and the founder and director of Warner Chilcott PLC from 1994 to 2002. From 2001 to 2010, Mr. Lynch was a member of the Board of IDA Ireland (an Irish government investment agency).

Mr. Lynch received his B.Sc. in Economics from Queen's University of Belfast in 1978, and qualified as a chartered accountant with KPMG in 1983 and served as a partner in that firm from 1990 to 1993.